COMP <GO>
MSA vs ABBV // RETURN ON INVESTED CAPITAL (ROIC)
MSA Safety Incorporated (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: MSA 6
— ABBV 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ABBV
LAST: $178.57 (-0.33%) • MKT CAP: $6.91B
roic
16.60%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
roic
29.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MSA VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MSA | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.50% | 70.20% | -23.70 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 16.60% | 29.00% | -12.40 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 33.3x | -16.30 | MSA | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 3.47% | +0.80 | MSA | /fcf-yield <GO> |
| Operating Margin | 19.80% | 24.60% | -4.80 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 6.90% | +8.00 | MSA | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 8.60% | -4.90 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.19% | 2.27% | -1.08 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 5.33 | +0.50 | MSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.40% | -0.90 | MSA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.1 | 72.8 | -28.70 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 1.15 | -0.28 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.1x | 113.1x | -90.00 | MSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.91B | $513.86B | -$506.95B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MSA REV | ABBV REV | MSA GROSS % | ABBV GROSS % | MSA FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.87B | $61.16B | 46.5% | 70.2% | $295.4M | $17.82B |
| FY 2024 | $1.81B | $56.33B | 47.6% | 70.0% | $242.2M | $17.83B |
| FY 2023 | $1.79B | $54.32B | 44.0% | 44.0% | $12.4M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MSA // BETA 0.87
ABBV // BETA 1.15